Donald Manning

Donald Manning has over 25 years of experience in the pharmaceutical industry, specializing in clinical development. Donald is currently the Chief Medical Officer at Exalys Therapeutics, and was previously with Adynxx, Inc., King Pharmaceuticals, Shionogi Inc., and Celgene. Manning began their career as an Assistant Professor at the University of Virginia Health System and Johns Hopkins Hospital.

Donald Manning completed a Fellowship in Pain Management and Regional Anesthesia at The Johns Hopkins University School of Medicine, followed by a Residency in Anesthesiology and Critical Care Medicine at the same school. Donald then did an Internship in Internal Medicine at Union Memorial Hospital. Donald has also completed a Fellowship in Neurological Surgery, Electrophysiology and Psychophysics at The Johns Hopkins University School of Medicine. In addition, they have an MD from The Johns Hopkins University School of Medicine and a PhD in Neuropharmacology from the same school. Donald also has a BSc in Physiology and Biochemistry from McGill University. Donald is certified by the American Board of Medical Specialties (ABMS) in American Board of Anesthesiology and by the Department of Health Professions in Medical Doctor. Donald also has a Certificate of Added Qualifications in Pain Management from the American Board of Medical Specialties (ABMS).